BONEFOS

This brand name is authorized in Brazil, Finland, Hong Kong SAR China, Netherlands, Tunisia.

Active ingredients

The drug BONEFOS contains one active pharmaceutical ingredient (API):

1	Clodronic acid UNII 0813BZ6866 - CLODRONIC ACID
	Clodronic acid is a bisphosphonate, (formerly diphosphonates), a group of analogues of pyrophosphate, which have been shown, in vitro, to inhibit the formation and dissolution of calcium phosphate (hydroxyapatite). In vivo, they have been shown to inhibit bone resorption to a greater or lesser extent, depending on the compound, and clodronate is one of the most effective in this respect.
	Read more about Clodronic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BONEFOS Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M05BA02	Clodronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538900801114317, 538900802153316
FI	Lääkealan turvallisuus- ja kehittämiskeskus	081430, 107243
HK	Department of Health Drug Office	35885
NL	Z-Index G-Standaard, PRK	48194
TN	Direction de la Pharmacie et du Médicament	7243011